At Alyors Holding, we take immense pride in our commitment to innovation, driven by cutting-edge technology and relentless research. Investment in Research and Development (R&D) lies at the heart of our corporate philosophy. Alyors Holding has made substantial investments to foster an environment where innovation flourishes, and ideas materialize into cutting-edge technologies. This investment not only drives our business forward but also positions us as a trailblazer.
Nuvita Biosearch Center, certified by the Turkish Ministry of Industry, stands as a testament to our unwavering dedication to pushing the boundaries of what's possible. With a strategic focus on biosearch and leveraging the latest in scientific research, we channel our resources to develop revolutionary solutions that cater to the evolving needs of our customers.
What sets us apart is that we are the only laboratory in Turkey that works with both bacteria and microalgae. Our state-of-the-art facilities include a pilot facility that is capable of performing all genetic analyzes, as well as a full-fledged technology laboratory.
Join us at Alyors Holding and Nuvita Biosearch Center as we lead the way in certified, groundbreaking solutions, excelling in both bacteria and microalgae research. Unleash possibilities with us.
Our R&D Studies:
- Production of raw probiotic materials from bacteria isolated from milk and newborn stool samples in Turkey (30 types of probiotics)
- Vegan omega 3, vitamin D, beta carotene, and astaxanthin synthesis technology from microalgae
- The only laboratory in Turkey that works with both bacteria and microalgae
- A pilot facility capable of performing all genetic analyzes
- A full-fledged technology laboratory
New Product R&D:
- TSE COVID-19 Safe Production Certificate
-
Analysis and tests using advanced technological devices:
- Vitamin analysis in HPLC1 and UV2
- Fish oil EPA-DHA Omega 3 analysis in GC3
- Mineral analysis and heavy metal tests on AAS4
- Raw materal identification test on FTIR5
- All formulations determined by an expert staff of doctors and pharmacists.
- Around 250 new products in development between 2021-2025.
